Our Blog | Biosimilars & Generics | AAM

AAM President & CEO John Murphy III at GRx+Biosims 2024

Nov 8, 2024 | Jennifer Soup

GRx+Biosims 2024 Conference Recap

Sep 10, 2024 | AAM

Want to Save Patients Money on Medicine? No Need to Reinvent the Wheel

2024 U.S. Generic and Biosimilar Medicines Savings Report

Sep 5, 2024 | AAM

2024 Savings Report

Jun 25, 2024 | AAM

Senate Finance Committee Bill Addressing Drug Shortages Would Provide Long Overdue Relief from Penalties Hurting Generic Drug Market

Senior are paying more at the pharmacy

Apr 16, 2024 | Michael Sargent

Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why?

Trends Impacting the Long-Term Sustainability of Biosimilars panel at Access! 2024 in Tampa, FL

Feb 22, 2024 | Jennifer Soup

Access! 2024 - Charting a Sustainable Path for Generics and Biosimilars

2023 The U.S. Generic & Biosimilar Medicines Savings Report

Oct 20, 2023 | AAM

Fireside Chat between FDA Commissioner Dr. Robert Califf and AAM’s Interim President and CEO, David Gaugh

Oct 18, 2023 | Jennifer Soup

GRx+Biosims 2023 Conference Recap

Biocon Biologics

Sep 13, 2023 | Jewel Smith

Member Spotlight: Biocon Biologics

Semglee Launch Tracking 2023

Jul 17, 2023 | Craig Burton

Pharmacy Benefit Managers Are Blocking Patient Access to Biosimilar Insulin

AAM - Your Generics & Biosimilars Industry

Jun 28, 2023 | Monét Stanford

U.S. Patients Rely On Generic Medicines But Increases In Drug Shortages Reflect Challenges To Their Long-Term Sustainability

May 12, 2023 | Jewel Smith

Associate Members Spotlight: Antheia